Answers are grounded in this paper and cite their sources.
Establishes CSF orexin-A as a reliable biomarker for sleep disorders, indicating its potential in diagnostics.
= 0.297). This study establishes a high-specificity analytical framework as a practical reference standard for refined sleep disorder diagnostics and confirms that CSF orexin-A remains the currently the most reliable clinical biomarker.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: